Keep an eye on this today... 👀

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Thursday, July 6th. I hope you have a great day in the market. Let's get ready to trade! Markets 📈 U.S. indexes edged lower on Wednesday. The Russell 2K's underperformed with a 1.2% sell off. The Dow fell by 0.3%, while the Nasdaq lost 0.1% and the S&P 500 slid 0.2%. Index futures are trading in the red in today's premarket, with Dow and S&P 500 contracts showing losses of 0.4%. Today's ADP Employment Report will likely set the tone for the session, so keep a close eye out at 8:30 a.m.! 👀 Sponsored [A Secret Income Play with Steady Payouts]( Have you seen this? This little-known strategy has the potential to produce steady income, and retail traders are beginning to take notice. If used correctly, it can generate steady returns over long periods of time... And, you don't need to be a millionaire to make it work for you. [>> Click here, you won't believe how simple it is.]( Premarket Highlights 🔎 📉 Hawkish Fed Minutes Minutes from the Fed's June meeting were released yesterday, and the notes revealed that many central bank policymakers were in favor of raising rates in June, sending stocks lower in Monday's session. A July rate hike seems like a virtual certainty at this point, and I wouldn't be surprised if we saw two to three additional hikes before 2023 is through. What to Watch Today 👀 ADP Employment Today's ADP employment report will give investors a sneak preview of Friday's June Jobs report. So far, a strong labor market has been the savings grace of the U.S. economy, and it may be the only reason we have narrowly avoided a pronounced recession. If any cracks start to form in the labor market, it could spell big trouble for U.S. economic growth in 2023. Major Earnings 💰 Park Aerospace Corp. [PKE] ... AM Levi Strauss & Co [LEVI] ... PM Kura Sushi Usa, Inc. [KRUS] ... PM Simulations Plus, Inc. [SLP] ... PM Economy 🏗 ADP employment [Jun] ... 8:15a Initial jobless claims [Jul] ... 8:30a U.S. trade deficit [May] ... 8:30a Job openings [May] ... 10a ISM services [Jun] ... 10a Running Hot 🔥 Gainers - Akumin [AKU] >> +32.3% - Palatin [PTN] >> +15.2% - Biodesix [BDSX] >> +14.5% - Avalo Therapeutics [AVTX] >> +13.8% Decliners - Allarity Therapeutics [ALLR] >> (51.2%) - VBI Vaccines [VBIV] >> (26.8%) - Nymox Pharma [NYMX] >> (16.2%) - Altamira Therapeutics [CYTO] >> (17.6%) BioXcel Therapeutics [BTAI] - Last Close: $11.21 BioXcel Therapeutics is running hot in the wake of a recent clinical update. Earlier this week, the company shares promising topline results from a TRANQUILITY Phase 3 trial of BXCL501 for Alzheimer's-related agitation. The news sent BTAI to a 42.2% gain on Wednesday, and it's carrying the momentum into today's premarket. BTAI is one of this morning's top stocks with a 14.0% gain. My Take: BTAI experienced a big sell off last week, but the declines must've been overdone because share prices have rebounded significantly since then. Trading volume has spiked this week as well, so there could be more upside here. Coya Therapeutics [COYA] - Last Close: $4.15 News of a new executive higher is boosting shares of Coya Therapeutics. Wednesday morning, the biotech firm said it has appointed drug development veteran Dr. Fred Grossman to the positions of President & Chief Medical Officer. Dr. Grossman will succeed Dr. Adrian Hepner, effective July 17th, 2023, and he brings two decades of clinical development expertise with him. Prior to joining Coya, Dr. Grossman held executive positions at Eli Lilly, Johnson & Johnson, Bristol Myers Squibb, and Sunovion. COYA is up 15.9% in today's premarket. My Take: I'm not sure if this news really explains today's move, but it's the only story on my radar at the moment. COYA could have something else going on., so keep an eye on the headlines if you're interested in making a play here. Kazia Therapeutics [KZIA] - Last Close: $1.17 Kazia Therapeutics just landed a major regulatory win. This morning, the FDA awarded a Fast Track Designation (FTD) to Kazia's lead product, paxalisib, as a combination treatment for solid tumor brain metastases. Kazia says the designation will provide enhanced access to FDA regulators, and the drug may also be eligible for Accelerated Approval and Priority Review. Paxalisib was previously granted FTD for glioblastoma in 2020, so this is its second opportunity to access the benefits of the designation. KZIA is one of today's top movers with a 22.2% gain on elevated premarket trading volume. My Take: KZIA's paxalisib appears to be on the right path, and it could provide more catalysts for the stock in the months ahead. Mullen Automotive [MULN] - Last Close: $0.1709 Mullen Automotive is heating up in today's premarket. Yesterday, the EV maker announced the hiring of Christian Attar to combat the naked short-selling of its shares. Mullen said it made the decision after it received reports that it was the target of a "market manipulation scheme" involving illegal naked short selling. The company hired Attar in partnership with Warshaw, Burstein, LLP to investigate and expose any wrongdoing. The news sparked a 69.3% rally in shares of MULN on Wednesday, and the rally is continuing in today's premarket. MULN is currently up 45.5% on elevated premarket trading volume. My Take: MULN appears to be in big trouble. Shares were going for $10 just six months ago. There could be opportunities for short-term gains here, but the stock's long-term trajectory doesn't seem promising. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](